US Stock MarketDetailed Quotes

GLUE Monte Rosa Therapeutics

Watchlist
  • 4.020
  • +0.040+1.01%
Trading Aug 9 10:24 ET
246.72MMarket Cap-1810P/E (TTM)

Monte Rosa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Monte Rosa Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

1.06M

0.00%
EPS(YoY)

-0.53

+18.46%
Analyst Rating

Strong Buy

Jul 31, 2024

Monte Rosa Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.088M--
--2024/Q3-- / 1.088M--
--2024/Q24.695M / 1.349M--
--2024/Q11.064M / 1.400M--
--2023/Q40.000 / 15.146M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.088M--
--2024/Q3-- / 1.088M--
--2024/Q24.695M / 1.349M--
--2024/Q11.064M / 1.400M--
--2023/Q40.000 / 15.146M--

Unlock Free Earnings Estimates

Monte Rosa Therapeutics Earnings Reports

  • Monte Rosa Therapeutics | 10-Q: Quarterly report

    Aug 8 07:09 ET

  • Monte Rosa Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 9 07:47 ET

  • Monte Rosa Therapeutics | 10-K: FY2023 Annual Report

    Mar 14 07:48 ET

  • Monte Rosa Therapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 16:04 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-3.75%